Seraxis Employee Directory
Biotechnology ResearchMaryland, United States11-50 Employees
Seraxis is a biotechnology company focused on developing cell-based therapies for diabetes management. Its lead program, SR-02, envisions an islet replacement therapy for patients with insulin-requiring diabetes who also receive immunosuppression. The approach is described as the foundation for subsequent therapies designed for patients who do not require immune suppression. Based in Germantown, Maryland, Seraxis operates in the biotechnology research field and targets individuals with Type 1 diabetes or insulin-dependent Type 2 diabetes. Recent coverage indicates the company is exploring an islet organoid therapy to address hypoglycemia as part of its broader program.